Sources: 1BitterDB, 4ClinicalTrials, 7Cochrane Library, 10DGIdb, 14DrugBank, 29HMDB, 33IUPHAR, 46NDF-RT, 50Novoseek, 56PharmGKB, 68UMLSSee all MalaCards sources |
Drugs for Dengue Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB): (show top 50)
(show all 59)
| id | | Name | Status | Phase | Clinical Trials | Cas Number | PubChem Id |
|---|
| 1 | | Ketotifen | approved | Phase 4 | 22 | 34580-14-8, 34580-13-7 | 3827 | 10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-, (2E)-2-butenedioate (1:1) 116655-74-4 34580-13-7 4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one 4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one 4-(1-Methyl-4-piperidylidene)-9-hydrobenzo[a]thiopheno[3,2-d][7]annulen-10-one 4-(1-Methyl-piperidin-4-ylidene)-4,9-dihydro-1-thia-benzo[f]azulen-10-one 4-(1-methylpiperidin-4-ylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one AB00053575 AC-15945 AC1L1GSZ AKOS000541268 Alaway (TN) BAS 00444483 BIDD:GT0509 BPBio1_000575 BRD-K28936863-051-05-8 BRN 3983897 BSPBio_000521 BSPBio_002964 C19H19NOS CAS-34580-14-8 CHEBI:112957 CHEMBL534 CID3827 D08105 DB00920 DivK1c_000111 EINECS 252-099-7 HC 20-511 HMS2090F16 HSDB 7283 IDI1_000111 KBio1_000111 KBio2_000906 KBio2_003474 KBio2_006042 KBio3_002184 KBioGR_001289 KBioSS_000906 Ketotifen (INN) Ketotifen Fumarate | Ketotifen [INN:BAN] Ketotifene Ketotifene [INN-French] Ketotifene fumarate Ketotifeno Ketotifeno [INN-Spanish] Ketotifenum Ketotifenum [INN-Latin] Ketotifin Ketotiphen Ketotiphene L000753 LS-33820 Lopac-K-2628 Lopac0_000706 MolPort-001-933-278 NCGC00015580-01 NCGC00015580-02 NCGC00015580-03 NCGC00015580-09 NCGC00022572-02 NCGC00022572-04 NCGC00022572-05 NINDS_000111 Oprea1_335550 Oprea1_553550 Prestwick0_000371 Prestwick1_000371 Prestwick2_000371 Prestwick3_000371 SPBio_001275 SPBio_002442 STK048448 STOCK1S-14132 Spectrum2_001198 Spectrum3_001382 Spectrum4_000805 Spectrum5_001395 Spectrum_000426 Tocris-0784 UNII-X49220T18G Zaditor ketotifen | |
| | 2 | | Histamine | approved | Phase 4 | 1034 | 75614-87-8, 51-45-6 | 774 | .beta.-Imidazolyl-4-ethylamine 1H-Imidazole-4-ethanamine 1H-Imidazole-5-ethanamine 1avn 1qft 2-(1H-Imidazol-4-yl)ethanamine 2-(1H-Imidazol-4-yl)ethylamine 2-(1H-Imidazol-5-yl)ethanamine 2-(1H-Imidazol-5-yl)ethylamine 2-(1H-imidazol-4-yl)ethan-1-amine 2-(1H-imidazol-5-yl)ethanamine 2-(3H-Imidazol-4-yl)-ethylamine 2-(4-Imidazolyl)ethanamine 2-(4-Imidazolyl)ethylamine 2-Imidazol-4-yl-Ethylamine 2-Imidazol-4-ylethylamine 2-[4-Imidazolyl]ethylamine 4-(2-Aminoethyl)-1H-imidazole 4-(2-Aminoethyl)imidazole 4-Imidazoleethylamine 5-Imidazoleethylamine 51-45-6 53290_FLUKA 64422-25-9 924364-91-0 AC-13185 AC1L19ZT AC1Q54BV AC1Q54BW AKOS000274386 ALBB-005968 BCBcMAP01_000250 BSPBio_001117 BSPBio_002124 Bio1_000487 Bio1_000976 Bio1_001465 Bio2_000389 Bio2_000869 C00388 CCRIS 6535 CHEBI:18295 CHEMBL90 CID774 D08040 DivK1c_000308 EINECS 200-100-6 Eramin Ergamine Ergotidine F411C768-A159-4FC0-A195-291A08BB03AA Free histamine H7125_SIGMA HMS1362G19 HMS1792G19 HMS1990G19 HSDB 3338 HSM Histamine Histamine (DCF) Histamine Base Histamine [USAN] Histamine, Free Base Histaminum | Histaminum (TN) IDI1_000308 IDI1_002144 Imidazole-4-ethylamine Istamina Istamina [Italian] KBio1_000308 KBio2_000457 KBio2_001325 KBio2_003025 KBio2_003893 KBio2_005593 KBio2_006461 KBio3_000853 KBio3_000854 KBio3_001344 KBioGR_000457 KBioGR_001580 KBioSS_000457 KBioSS_001325 L-Histamin base L-Histamine L-histamine L000292 LS-75835 Lopac-H-7250 Lopac0_000595 MLS000069447 MolPort-001-785-597 MolPort-002-042-264 NCGC00015513-01 NCGC00015513-08 NCGC00093371-02 NCGC00093371-03 NCGC00093371-04 NCGC00093371-05 NINDS_000308 NSC 33792 NSC33792 SDCCGMLS-0066601.P001 SMP1_000151 SMR000059091 SPBio_000729 ST073926 STK346752 STOCK5S-55669 Spectrum2_000665 Spectrum3_000452 Spectrum4_000960 Spectrum5_000796 Spectrum_000845 Theramine UNII-820484N8I3 WLN: T5M CNJ D2Z ZERO/004089 [3H]histamine b-Imidazolyl-4-ethylamine beta-Aminoethylglyoxaline beta-Aminoethylimidazole beta-Aminothethylglyoxaline beta-Imidazolyl-4-ethylamine beta-aminothethylglyoxaline bmse000744 histamine nchembio.87-comp54 nchembio714-comp1 |
| | 3 | | Histamine Phosphate | approved | Phase 4 | 1033 | 51-74-1 | 65513 | 1H-Imidazole-4-ethanamine, phosphate (1:2) 2-Imidazol-4-ylethylamine orthophosphoric acid (1:2) 4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate) 4-(2-Aminoethyl)imidazole di-acid phosphate 4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate 51-74-1 53623-99-7 74-56-6 AC1L23E4 CID65513 D04445 DB00667 | EINECS 200-118-4 H0147 Histamine acid phosphate Histamine biphosphate Histamine dihydrogen phosphate Histamine diphosphate Histamine phosphate (1:2) Histamine phosphate (TN) Histamine phosphate (USP) Histamine phosphate [USP] Histamine positive Histaminum LS-78569 UNII-QWB37T4WZZ |
| | 4 | | Vaccines | | Phase 4, Phase 3, Phase 1, Phase 2 | 6428 | | | | 5 | | Neurotransmitter Agents | | Phase 4 | 17734 | | | | 6 | | Anti-Allergic Agents | | Phase 4 | 1490 | | | | 7 | | Dermatologic Agents | | Phase 4 | 5674 | | | | 8 | | Antipruritics | | Phase 4 | 864 | | | | 9 | | Histamine H1 Antagonists | | Phase 4 | 782 | | | | 10 | | Histamine Antagonists | | Phase 4 | 946 | | | | 11 | | Ivermectin | approved, vet_approved | Phase 2, Phase 3 | 57 | 70288-86-7 | 6474909, 46936176 | (2aE,4E,5'S,6S,6'R,7S,8E,11R,13R,15S,17aR,20R,20aR,20bS)-20,20b-dihydroxy-5',6,8,19-tetramethyl-6'-[(1S)-1-methylpropyl]-17-oxo-3',4',5',6,6',10,11,14,15,17,17a,20,20a,20b-tetradecahydro-2H,7H-spiro[11,15-methanofuro[4,3,2-pq][2,6]benzodioxacyclooctadecine-13,2'-pyran]-7-yl 2,6-dideoxy-4-O-(2,6-dideoxy-3-O-methyl-alpha-L-arabino-hexopyranosyl)-3-O-methyl-alpha-L-arabino-hexopyranoside 22,23-Dihydroxy-avermectin B 22,23-Dihyroavermectin B1 5-O-Demethyl-22,23-dihydro-avermectin A1a 71827-03-7 AB00513813 AC1MJ4GR AC1N7O27 BPBio1_000322 BRD-K24652731-001-02-7 BSPBio_000292 CHEMBL341047 CID11957587 CID4330618 CID6321424 CID6419971 CID6427057 EU-0100693 FT-0082656 HMS1568O14 | HMS2089M09 I 8898 I8898_SIGMA IVERMECTIN Ivermectin Ivermectina Ivermectine Ivermectinum Lopac0_000693 MK-933 MLS001333247 MLS001333248 MLS002153248 MolPort-006-394-715 NCGC00094047-01 NCGC00094047-02 NCGC00094047-03 Prestwick2_000156 Prestwick3_000156 Prestwick_516 S1351_Selleck SMR000857211 |
| | 12 | | Antiparasitic Agents | | Phase 2, Phase 3, Phase 1 | 2127 | | | | 13 | | Anti-Infective Agents | | Phase 2, Phase 3, Phase 1 | 21402 | | | | 14 | | Protective Agents | | Phase 3 | 7190 | | | | 15 | | Pharmaceutical Solutions | | Phase 3, Phase 2, Phase 1 | 7793 | | | | 16 | | Insect Repellents | | Phase 3 | 3 | | | | 17 | | DEET | | Phase 3 | 2 | | | | 18 | | Heptavalent Pneumococcal Conjugate Vaccine | | Phase 3, Phase 2 | 454 | | | | 19 | | Ribavirin | approved | Phase 2 | 984 | 36791-04-5 | 37542 | 1-.beta.-D-Ribofuranosyl-1,2,4-triazolo-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,4-triazole-3-carboxamide 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-1,2,4-triazole-3-carboxamide 1-beta-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide 1-beta-D-Ribofuranosyl-1H-1,2,4-triazole-3-carboxamide 1-beta-D-ribofuranosyl-1-H-1,2,4-triazole-3-carboxamide 36791-04-5 437710-49-1 66510-90-5 AA-504/07617051 AB00430481 AC1L1XXZ AC1Q1IDC AC1Q4ZGS AKOS001715163 BB_NC-0567 BPBio1_001195 BRN 0892462 BSPBio_001085 BSPBio_003352 C-Virin CHEMBL1643 CID37542 Copegus Copegus (TN) Cotronak D00423 DB00811 DRG-0028 DivK1c_000782 Drug: Ribavirin EU-0101063 FT-0082885 HMS2090L15 HMS2094O09 HMS502H04 HSDB 6513 ICN-1229 IDI1_000782 KBio1_000782 KBio2_002328 KBio2_004896 KBio2_007464 KBio3_002854 KBioGR_001804 KBioSS_002331 KS-1104 LS-1241 Lopac0_001063 MLS000028486 MLS002222317 MolPort-002-507-104 MolPort-002-885-856 NCGC00090726-01 NCGC00090726-03 NCGC00090726-04 NCGC00090726-05 NCGC00090726-06 NCGC00090726-07 NINDS_000782 NSC 163039 | NSC163039 Prestwick3_000993 R 9644 R-964 R9644_SIGMA RBV RG-964 RIBAV RTC RTCA RTP Ravanex Rebetol Rebetol (TN) Rebetron Rebretron Ribacine Ribamide Ribamidil Ribamidyl Ribasphere Ribasphere (TN) Ribav Ribavirin Ribavirin (JAN/USP/INN) Ribavirin Capsules Ribavirin Triphosphate Ribavirin [USAN:INN] Ribavirin-TP Ribavirina Ribavirina [INN-Spanish] Ribavirine Ribavirine [INN-French] Ribavirinum Ribavirinum [INN-Latin] Ribovirin Ro 20-9963/000 Ro-20-9963 S2504_Selleck SCH 18908 SMP1_000261 SMR000058315 SPECTRUM1503938 SR-01000076112-3 Spectrum3_001876 Spectrum4_001252 Spectrum5_002075 Spectrum_001826 Tribavirin UNII-49717AWG6K Varazid Vilona Viramid Viramide Virazid Virazide Virazole Virazole (Ribavirin) Inhalation Solution Virazole (TN) Virazole 5'-triphosphate ZINC01035331 ribavirin | |
| | 20 | | Hydrocortisone | approved, vet_approved | Phase 2 | 640 | 50-23-7 | 5754, 657311 | (11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione (11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione 11-Hydrocortisone 11-beta-Hydrocortisone 11-beta-Hydroxycortisone 11a-Hydroxycorticosterone 11alpha-Hydroxycorticosterone 11b,17,21-Trihydroxyprogesterone 11b-Hydrocortisone 11b-Hydroxycortisone 11beta,17,21-Trihydroxyprogesterone 11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione 11beta-Hydrocortisone 11beta-Hydroxycortisone 11beta-hydrocortisone 11β-hydrocortisone 17-Hydroxycorticosterone 17a-Hydroxycorticosterone 17alpha-Hydroxycorticosterone 2v95 4-Pregnen-11beta,17alpha,21-triol-3,20-dione 4-Pregnene-11alpha,21-triol 3,20-dione 4-Pregnene-11b,17a,21-triol-3,20-dione 50-23-7 8056-08-4 80562-38-5 8063-42-1 AC-12902 AC1L1L2B ACETASOL HC ACETIC ACID W/ HYDROCORTISONE AI3-25006 AKOS001582651 Acticort Acticort (TN) Aeroseb HC Aeroseb-HC Ala-Cort Ala-Scalp Alacort Algicirtis Alphaderm Amberin Anflam Anti-inflammatory hormone Anucort Anucort-HC Anusol HC Anusol HC (TN) Aquacort Aquanil HC B48448A1-24BA-47CA-8D9E-43E5BC949386 BPBio1_000544 BRD-K93568044-001-03-1 BSPBio_000494 Balneol-hc Barseb HC Basan-Corti Beta-hc Bio-0648 C00735 C21H30O5 CCRIS 5854 CHEBI:17650 CHEMBL389621 CID5754 COR-OTICIN CPD000653523 CaldeCORT Spray Cetacort Chronocort Clear aid Cleiton Cobadex Colocort Colocort (TN) Compound F Compound F (kendall) Cor-Tar-Quin Corhydron Cort-Dome Cort-Quin Cortanal Cortef Cortef (TN) Cortenema Cortesal Corticreme Cortifair Cortifan Cortifoam Cortiment Cortisol Cortisol alcohol Cortisol, Hydrocortisone Cortisolonum Cortisporin Cortisporin Otico Cortispray Cortizol Cortolotion Cortonema Cortoxide Cortril Cremesone Cremicort-H Cutisol Cyclodextrin-encapsulated hydrocortisone D00088 DB00741 DB07886 Delacort Derm-Aid Dermacort Dermaspray Dermil Dermocortal Dermolate Dihydrocostisone Dioderm Dome-cort Domolene-HC Drotic DuoCort EINECS 200-020-1 EU-0100594 Ef corlin Efcorbin Efcortelan Efcortelin Eldecort Eldercort Epicort Epicortisol Epiderm H Esiderm H Evacort Ficortril Fiocortril Flexicort Foille Insetti Genacort Genacort (lotion) Glycort Gyno-Cortisone H 4001 H-Cort H0135_SIGMA H0396_SIGMA H0888_SIGMA H3160_SIGMA H4001_SIGMA H6909_SIGMA HC HC #1 | HC #4 HC (HYDROCORTISONE) HMS1569I16 HMS2090M04 HSDB 3339 HYDROCORTISONE AND ACETIC ACID HYDROCORTISONE IN ABSORBASE Heb Cort Heb-Cort Hi-cor Hidalone Hidro-Colisona Hidrocortisona Hidrocortisona [INN-Spanish] Hycort Hycortol Hycortole Hydracort Hydrasson Hydro-Adreson Hydro-Colisona Hydro-RX Hydro-colisona Hydrocort Hydrocortal Hydrocorticosterone Hydrocortisone Hydrocortisone (JP15/USP/INN) Hydrocortisone Acetate Hydrocortisone Base Hydrocortisone Butyrate Hydrocortisone Sodium Phosphate Hydrocortisone Valerate Hydrocortisone [INN:BAN:JAN] Hydrocortisone alcohol Hydrocortisone base Hydrocortisone free alcohol Hydrocortisone solution Hydrocortisone-Water Soluble Hydrocortisonum Hydrocortisonum [INN-Latin] Hydrocortistab Hydrocortisyl Hydrocortone Hydroskin Hydroxycortisone Hysone Hytisone Hytone Hytone (TN) Hytone lotion Idrocortisone Idrocortisone [DCIT] Incortin-H Incortin-hydrogen Kendall'S compound F Kendall's compound F Komed HC Kyypakkaus LMST02030001 LS-7439 Lacticare HC Lacticare-HC Lactisona Lopac0_000594 Lubricort MLS000069609 MLS001148103 MLS002207135 MLS002222189 Maintasone Medicort Meusicort Mildison Milliderm MolPort-001-794-637 NCGC00022848-06 NCGC00022848-07 NCGC00022848-09 NCGC00022848-12 NCI60_000118 NSC 10483 NSC-10483 NSC10483 Neo-Cort-Dome Neo-Cortef Neosporin-H Ear Nogenic HC Nutracort Nystaform-HC ORLEX HC Optef Otalgine Otic-Neo-Cort-Dome Otobiotic Otocort Otosone-F Pediotic Suspension Penecort Permicort Polcort H Preparation H Hydrocortisone Cream Prepcort Prestwick0_000447 Prestwick1_000447 Prestwick2_000447 Prestwick3_000447 Prestwick_265 Prevex HC Proctocort Proctofoam Proctozone HC Protocort Racet Rectasol-HC Rectoid Reichstein'S substance M Reichstein's substance M Remederm HC S1696_Selleck SAM002264617 SMP1_000156 SMR000059022 SMR000653523 SPBio_002433 Sanatison Scalp-Cort Scalpicin Capilar Schericur Scheroson F Sigmacort Signef Stie-cort Stiefcorcil Synacort Systral Hydrocort Tarcortin Texacort Texacort lotion 25 Timocort Topicort Transderma H Traumaide UNII-WI4X0X7BPJ UPCMLD-DP133 UPCMLD-DP133:001 Uniderm Vioform-Hydrocortisone VoSol HC Vytone Zenoxone [3H]cortisol component of Lubricort component of Neo-Cort-Dome component of Otalgine hydrocortisone | |
| | 21 | | chloroquine | approved, vet_approved | Phase 1, Phase 2 | 147 | 54-05-7 | 2719 | ( -)-Chloroquine (+)-Chloroquine (-)-Chloroquine (R)-(-)-Chloroquine 3377 RP opalate 3545-67-3 50-63-5 54-05-7 56598-66-4 58175-86-3 58175-87-4 7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline 7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline AB00053436 AC1L1EB8 AC1Q2ZA7 AC1Q2ZA8 Amokin Aralen Aralen HCl Arechin Arechine Arequin Arolen Arthrochin Artrichin Avlochlor Avloclor BPBio1_000655 BRD-A91699651-065-01-1 BRN 0482809 BSPBio_000595 BSPBio_002001 Bemaco Bemaphate Bemasulph Benaquin Bipiquin C07625 C18H26ClN3 CCRIS 3439 CHEBI:3638 CHEMBL76 CID2719 CQ CU-01000012392-2 Capquin Chemochin Chingamin Chloraquine Chlorochin Chlorochine Chlorochinum Chloroin Chloroquin Chloroquina Chloroquine Chloroquine (USP/INN) Chloroquine (VAN) Chloroquine Bis-Phosphoric Acid Chloroquine Phosphate Chloroquine [USAN:INN:BAN] Chloroquine phosphate Chloroquinium Chloroquinum Chloroquinum [INN-Latin] Chlorquin Cidanchin Clorochina Clorochina [DCIT] Cloroquina Cloroquina [INN-Spanish] Cocartrit D02366 DB00608 Dawaquin Delagil Dichinalex DivK1c_000404 EINECS 200-191-2 Elestol Gontochin Gontochin phosphate HMS2090O03 HSDB 3029 Heliopar Hydroxychloroquine Sulfate IDI1_000404 Imagon | Ipsen 225 Iroquine KBio1_000404 KBio2_000592 KBio2_003160 KBio2_005728 KBio3_001221 KBioGR_000778 KBioSS_000592 Khingamin Klorokin LS-141726 Lapaquin Lopac0_000296 Malaquin Malaquin (*Diphosphate*) Malaren Malarex Mesylith Miniquine MolMap_000009 MolPort-001-783-623 N(4)-(7-chloro-4-Quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine NCGC00015256-04 NCGC00162120-01 NCI60_000894 NINDS_000404 NSC 187208 NSC14050 NSC187208 Neochin Nivachine Nivaquine Nivaquine B Pfizerquine Plaquenil Prestwick0_000548 Prestwick1_000548 Prestwick2_000548 Prestwick3_000548 Quinachlor Quinagamin Quinagamine Quinercyl Quingamine Quinilon Quinoscan RP 3377 RP-3377 Resochen Resochin Resoquina Resoquine Reumachlor Reumaquin Rivoquine Ro 01-6014/N2 Ronaquine Roquine SMP2_000034 SN 6718 SN-7618 SPBio_000174 SPBio_002516 ST 21 ST 21 (pharmaceutical) Sanoquin Silbesan Siragan Solprina Sopaquin Spectrum2_000127 Spectrum3_000341 Spectrum4_000279 Spectrum5_000707 Spectrum_000132 Tanakan Tanakene Tresochin Trochin UNII-886U3H6UFF W 7618 WIN 244 WLN: T66 BNJ EMY1&3N2&2 IG chloroquine nchembio.215-comp4 nchembio.368-comp8 nchembio.87-comp17 {4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine |
| | 22 | | Neomycin | approved, vet_approved | Phase 1, Phase 2 | 48 | 1404-04-2 | 8378 | (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol 11025-81-3 119-04-0 1393-86-8 1404-04-2 1405-10-3 (sulfate (salt)) 4-18-00-07476 (Beilstein Handbook Reference) 72131_FLUKA AB00443887 AC1L1QVH Actilin Actiline Antibiotic 10676 Antibiotic produced by Streptomyces decaris. Neomycin B Antibiotique BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG BDG-(1-4)NEB-(5-1)RIB-(3-1)NED BPBio1_000326 BRN 0101621 BSPBio_000296 C01737 C23H46N6O13 C25H50N6O13 CCRIS 5462 CHEBI:7508 CID8378 Caswell No. 595 D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy D05140 DB00452 DB00994 EINECS 204-292-2 EINECS 215-766-3 EPA Pesticide Chemical Code 006303 Endomixin Enterfram Fradiomycin Fradiomycin B Fradiomycinum Framicetina Framicetina [INN-Spanish] Framycetin Framycetin (INN) Framycetin [INN:BAN:DCF] Framycetine Framycetine [INN-French] Framycetinum Framycetinum [INN-Latin] | Framygen Fraquinol HMS2089P15 HSDB 3242 LS-96091 LS-96095 MolPort-003-938-736 Myacine Myacyne Mycifradin Myciguent N1142_SIGMA NCGC00179612-01 NEOMYCIN AND POLYMYXIN B SULFATES NEOMYCIN B NEOMYCIN SULFATE NMY Neo-Fradin Neo-Rx Neobiotic Neobrettin Neolate Neomas Neomcin Neomicina Neomicina [DCIT] Neomin Neomycin B Sulfate Neomycin B sulfate Neomycin Sulfate Neomycin Sulphate Neomycin solution Neomycine Neomycine [INN-French] Neomycinum Neomycinum [INN-Latin] Nivemycin PIMAVECORT Prestwick3_000158 ST075177 Soframycin Soframycin Ophthalmic Soframycine Tuttomycin UNII-4BOC774388 UNII-I16QD7X297 USAF CB-19 VONAMYCIN Vonamycin powder V neomycin | |
| | 23 | | Antiviral Agents | | Phase 2 | 9732 | | | | 24 | | Hydrocortisone acetate | | Phase 2 | 640 | | | | 25 | | Peripheral Nervous System Agents | | Phase 1, Phase 2 | 22776 | | | | 26 | | Hydrocortisone 17-butyrate 21-propionate | | Phase 2 | 640 | | | | 27 | | Cortisol succinate | | Phase 2 | 640 | | | | 28 | | Antimetabolites | | Phase 2 | 11774 | | | | 29 | | Chloroquine diphosphate | | Phase 1, Phase 2 | 147 | 50-63-5 | | | 30 | | Analgesics, Non-Narcotic | | Phase 1, Phase 2 | 6260 | | | | 31 | | Analgesics | | Phase 1, Phase 2 | 11287 | | | | 32 | | Anti-Inflammatory Agents | | Phase 1, Phase 2 | 10355 | | | | 33 | | Anthelmintics | | Phase 1, Phase 2 | 431 | | | | 34 | | Antirheumatic Agents | | Phase 1, Phase 2 | 10627 | | | | 35 | | Anti-Inflammatory Agents, Non-Steroidal | | Phase 1, Phase 2 | 4295 | | | | 36 | | Antiprotozoal Agents | | Phase 1, Phase 2 | 1986 | | | | 37 | | Antimalarials | | Phase 1, Phase 2 | 1216 | | | | 38 | | Hemostatics | | Phase 2 | 1359 | | | | 39 | | Coagulants | | Phase 2 | 1428 | | | | 40 | | Antibodies | | Phase 1, Phase 2 | 6045 | | | | 41 | | Immunoglobulins | | Phase 1, Phase 2 | 6045 | | | | 42 | | Aluminum hydroxide | approved | Phase 1 | 201 | 21645-51-2 | | Al(OH)3 Aluminium hydroxide Aluminium hydroxide gel, dried | Aluminium hydroxide, dried Aluminum hydroxide gel, dried Aluminum hydroxide, dried Dried aluminium hydroxide Dried aluminum hydroxide gel |
| | 43 | | Adjuvants, Immunologic | | Phase 1 | 2484 | | | | 44 | | Anti-Ulcer Agents | | Phase 1 | 1767 | | | | 45 | | Gastrointestinal Agents | | Phase 1 | 8109 | | | | 46 | | Antacids | | Phase 1 | 1767 | | | | 47 | | Aluminum sulfate | | Phase 1 | 87 | | | | 48 | | Papaya | Nutraceutical | Phase 1 | 16 | | | | 49 | | Acetaminophen | approved | | 978 | 103-90-2 | 1983 | 4'-Hydroxyacetanilide 4'-hydroxyacetanilide 4-(Acetylamino)phenol 4-Acetamidophenol 4-Acetaminophenol 4-Hydroxyacetanilide 4-Hydroxyanilid kyseliny octove 4-acetamidophenol A-Per A.F. Anacin AC1Q1KYJ AC1Q1KYK APAP Abenol Abensanil Abrol Abrolet Acamol Accu-Tap Acenol Acephen Acertol Aceta Elixir Aceta Tablets Acetaco Acetagesic Acetalgin Acetaminofen Acetaminophen Acetaminophen Uniserts Acetamol Acetavance Acetofen Actamin Actamin Extra Actamin Super Actifed Plus Actimol Actimol Chewable Tablets Actimol Children'S Suspension Actimol Infants' Suspension Actimol Junior Strength Caplets Actron Afebrin Afebryl Aferadol Algesidal Algina Algomol Algotropyl Allay Alpiny Alpinyl Alvedon Amadil Aminofen Aminofen Max Anacin Anacin 3 Anacin-3 Anacin-3 Extra Strength Anadin dla dzieci Anaflon Analter Anapap Andox Anelix Anexsia Anexsia 10/660 Anexsia 5/325 Anexsia 7.5/325 Anexsia 7.5/650 Anhiba Anoquan Anti-Algos Antidol Anuphen Apacet Apacet Capsules Apacet Elixir Apacet Extra Strength Caplets Apacet Extra Strength Tablets Apacet Regular Strength Tablets Apadon Apamid Apamide Apitrelal Apo-Acetaminophen Arfen Arthralgen Asetam Asomal Aspac Aspirin Free Anacin Maximum Strength Caplets Aspirin Free Anacin Maximum Strength Gel Caplets Aspirin Free Anacin Maximum Strength Tablets Aspirin-Free Anacin Aspirin-Free Excedrin Caplets Asplin Atasol Atasol Caplets Atasol Drops Atasol Forte Caplets Atasol Forte Tablets Atasol Oral Solution Atasol Tablets Atralidon Babikan Bacetamol Bancap Bancap Hc Banesin Bayer Select Bayer Select Allergy-Sinus Bayer Select Head Cold Bayer Select Headache Pain Bayer Select Maximum Strength Headache Pain Relief Formula Bayer Select Menstrual Multi-Symptom Bayer Select Sinus Pain Relief Ben-u-ron Benmyo Bickie-mol Biocetamol Bucet Butalbital Butapap CCRIS 3 CHEBI:46195 Cadafen Calapol Calmanticold Calonal Calpol Capital Capital with Codeine Captin Causalon Cefalex Cetadol Children'S Acetaminophen Elixir Drops Children'S Acetaminophen Oral Solution Children'S Tylenol Chewable Claradol Codeine Clixodyne Co-Gesic Cod-Acamol Forte Codabrol Codalgin Codapane Codicet Codisal Codisal Forte Codoliprane Codral Pain Relief Cofamol Conacetol Contac Cough & Sore Throat Formula Contra-Schmerz P Coricidin Coricidin D Coricidin Sinus Cosutone Croix Blanche Cuponol Curadon Curpol Custodial D oliprane Dafalgan Dapa Dapa X-S Darocet Darvocet Darvocet-N 50 Datril Datril Extra-Strength Daygrip Demilets Deminofen Democyl Demogripal Desfebre Dhamol Dhc Plus Dial-a-gesic Dial-alpha-gesic Dimindol Dirox Disprol Dol-Stop Dolcor Dolefin Dolegrippin Dolene AP-65 Dolene Ap-65 Dolgesic Doliprane Dolko Dolofugin Doloreduct Dolorfug Dolorol Forte Dolorstop Dolotec Dolprone Dorocoff Dresan Dristan Cold No Drowsiness Dristancito Drixoral Plus Duaneo Dularin Duorol Duracetamol Duradyne Dhc Durapan Dymadon Dymadon Co Dymadon Forte Dypap Ecosetol Elixodyne Empracet Endecon Enelfa Eneril Esgic Esgic-Plus Eu-Med Excedrin Excedrin Caplets Excedrin Extra Strength Caplets Excipain Exdol Exdol Strong Fanalgic Farmadol Febranine Febrectal Febrectol Febrex Febricet Febridol Febrilix Febrin Febrinol Febro-Gesic Febrolin Femcet Fendon Fensum Fepanil Fever All Feverall Feverall Junior Strength Feverall Sprinkle Caps Junior Strength Fevor Finimal Finiweh Fioricet Fluparmol Fortalidon P Freka-cetamol Gattaphen T Gelocatil Geluprane Genapap Genapap Children'S Elixir Genapap Children'S Tablets Genapap Extra Strength Caplets Genapap Extra Strength Tablets Genapap Regular Strength Tablets Genebs Genebs Extra Strength Caplets Genebs Regular Strength Tablets Genebs X-Tra Geralgine-P Gripin Bebe Grippostad Gynospasmine Hedex Helon N Homoolan Hy-Phen Hycomine Compound Hydrocet Ildamol Inalgex Infadrops Infants' Feverall Influbene N Injectapap Intensin Janupap Jin Gang Junior Disprol KBio1_000660 Kataprin Kinder Finimal Korum Kratofin simplex L024125 Labamol Lekadol Lemgrip Lemsip Lestemp Liqiprine Liquagesic Liquigesic Co Liquiprin Liquiprin Children'S Elixir Liquiprin Infants" Drops Lonarid Lonarid Mono Lorcet-Hd Lortab Lupocet Lyteca Lyteca Syrup Magnidol Malex N Malgis Malidens Maxadol Medigesic Plus Medinol Paediatric Medocodene Melabon Infantil Mexalen Midol Maximum Strength Midol PM Night Time Formula Midol Regular Strength Midol Teen Formula Migraleve Yellow Minafen Minoset Miralgin Momentum Mono Praecimed | Multin N-(4-Hydroxyphenyl)acetamide N-Acetyl-4-aminophenol N-Acetyl-p-aminophenol N-acetyl-p-aminophenol NAPA NCX 701 NEBS NSC3991 Naldegesic Napafen Napap Naprinol Nealgyl Nebs Neo-Fepramol NeoCitran Neodol Neodolito Neopap Neotrend Neuridon New Cortal for Children NilnOcen Nina No-Febril Nobedon Nodolex Noral Norcet Norco O-Acetaminophenol Ofirmev Oltyl Oralgan Oraphen-PD Ortensan Oxycet Oxycocet Oxycodone 2.5/Apap 500 Oxycodone 5/Apap 500 PCM Paracetamol Lichtenstein Paceco Pacemo Pacemol Pacet Pacimol Paedialgon Paedol Painex Paldesic Pamol Panacete Panadeine Panadeine Co Panadiene Panado-Co Panado-Co Caplets Panadol Panadol Extra Strength Panadol Junior Strength Caplets Panadol Maximum Strength Caplets Panadol Maximum Strength Tablets Panale ve Panaleve Panamax Panasorb Panasorbe Panets Panex Panodil Panofen Pantalgin Papa-Deine Papa-Deine #3 Papa-Deine #4 Para-Suppo Para-Tabs Paracemol Paracenol Paracet Paracetamol Paracetamol AL Paracetamol Antipanin P Paracetamol BC Paracetamol Basics Paracetamol DC Paracetamol Dr. Schmidgall Paracetamol Fecofar Paracetamol Genericon Paracetamol Hanseler Paracetamol Harkley Paracetamol Heumann Paracetamol Hexal Paracetamol Italfarmaco Paracetamol Nycomed Paracetamol PB Paracetamol Raffo Paracetamol Ratiopharm Paracetamol Rosch Paracetamol Saar Paracetamol SmithKline Beecham Paracetamol Stada Paracetamol Winthrop Paracetamol von ct Paracetamole Paracetamolo Paracetamolum Paracetanol Paracetol Paracin Paracod Paracodol Paracétamol Parador Paradrops Parakapton Parake Paralen Paralief Paralink Paralyoc Paramol Paramolan Paranox Parapan Parasedol Parasin Paraspen Parcetol Parelan Parmol Parogal Paroma Pasolind Pasolind N Pe-Tam Pediapirin Pediatrix Pedric Percocet Percocet-5 Percocet-Demi Percogesic with Codeine Perdolan Mono Perfalgan Phenaphen Phenaphen Caplets Phenaphen W/Codeine Phendon Phenipirin Phogoglandin Phrenilin Phrenilin Forte Pinex Piramin Pirinasol Plicet Polmofen Predimol Predualito Prestwick_13 Prodol Prompt Prontina Propacet Propacet 100 Proval #3 Puernol Pulmofen Pyregesic-C Pyrigesic Pyrinazine Pyromed Quiet World Redutemp Reliv Remedol Rhinex D-Lay Tablets Rivalgyl Robigesic Robitussin Night Relief Rockamol Plus Rounox Roxicet Roxicet 5/500 Roxilox RubieMol Rubophen Rupemol SK-Apap SPBio_002836 Salzone Sanicet Sanicopyrine Scanol Scentalgyl Scherzatabletten Rezeptur 534 Schmerzex Sedalito Sedapap Semolacin Servigesic Seskamol Setakop Setamol Setol Sifenol Sinaspril Sine-Off Sinus Medicine Caplets Sinedol Sinmol Sinubid Snaplets-FR Spalt N Spalt fur die nacht St Joseph Aspirin-Free St Joseph Aspirin-Free for Children St. Joseph Cold Tablets for Children St. Joseph Fever Reducer Stanback Stopain Sudafed Severe Cold Formula Sudafed Sinus Sunetheton Supac Supadol mono Supofen Suppap Suppap-120 Suppap-325 Suppap-650 Supramol-M Synalgos-Dc-A TYL Tabalgin Tachiprina Talacen Tapanol Tapanol Extra Strength Caplets Tapanol Extra Strength Tablets Tapar Tavist Allergy/Sinus/Headache Tazamol Temlo Tempanal Tempra Tempra Caplets Tempra Chewable Tablets Tempra D.S Tempra Drops Tempra Syrup Tencon Termacet Termalgin Termalgine Termofren TheraFlu Tibinide Tibizide Tiffy Tisin Tisiodrazida Titralgan Tizide Tocris-1706 Toximer P Tralgon Treupel N Treupel mon Treuphadol Triad Triaminic Sore Throat Formula Triaprin Tricoton Tussapap Ty lenol Tycolet Tylenol Tylenol (TN) Tylenol Allergy Sinus Tylenol Arthritis Extended Relief Tylenol Caplets Tylenol Children'S Chewable Tablets Tylenol Children'S Elixir Tylenol Children'S Suspension Liquid Tylenol Drops Tylenol Elixir Tylenol Extra Strength Adult Liquid Pain Reliever Tylenol Extra Strength Caplets Tylenol Extra Strength Gelcaps Tylenol Extra Strength Tablets Tylenol Gelcaps Tylenol Infants Drops Tylenol Infants" Suspension Drops Tylenol Junior Strength Caplets Tylenol Junior Strength Chewable Tablets Tylenol Regular Strength Caplets Tylenol Regular Strength Tablets Tylenol Tablets Tylex Tylex CD Tylol Tylox Tylox-325 Tymol Ultracet Upsanol Utragin Valadol Valgesic Valorin Valorin Extra Vanquish Veralgina Vermidon Verpol Viclor Richet Vicodin Vicodin Es Vicodin Hp Vips Viruflu Vivimed Volpan Wygesic Zatinol Zolben acetaminofén acétaminophène alpha-Per p-(Acetylamino)phenol p-Acetamidophenol p-Acetaminophenol p-Acetylaminophenol p-Hydroxyacetanilide p-Hydroxyphenolacetamide p-acetamidophenol p-acetaminophenol p-hydroxy-acetanilid p-hydroxyacetanilide p-hydroxyphenolacetamide |
| | 50 | | Artesunate | approved | | 181 | 88495-63-0 | 6917864, 5464098 | (3R,5aS,6R,8aS,9R,10S,12R,12aR)-Decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-ol, hydrogen succinate 112346-66-4 182824-33-5 252637-87-9 4-Oxo-4-(((3R,5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxypyrano(4,3-j)-1,2-benzodioxepin-10-yl hydrogen butanedioate 4-oxo-4-{[(3r,5as,6r,8as,9r,10r,12r,12ar)-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl]oxy}butanoic acid 4-oxo-4-{[(5aS,6R,8aS,9R,10S,12R,12aR)-3,6,9-trimethyldecahydro-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl]oxy}butanoic acid 83507-69-1 88495-63-0 91487-94-4 AC1L23PW AC1L2XWW AC1L4FU0 AC1Q5VRV AKOS004119951 AS Ambap88495-63-0 Arinate Arsumax Arsumax (TN) Artesunate Artesunate (USAN) Artesunate (superseded RN) Artesunato Artesunato [INN-Spanish] Artesunatum Artesunatum [INN-Latin] Artesunic acid Artsuna BB_NC-1045 Butanedioic acid, mono((3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-yl) ester Butanedioic acid, mono(decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin-10-yl) ester C19H28O8 CHEMBL218601 CHEMBL258608 CID105031 CID11520210 CID11988384 CID156252 | CID5464098 CID65664 CID6917864 CID9821433 CPD000466336 D02482 Dihydroartemisinine-12-alpha-succinate Dihydroqinghaosusuccinate Dihydroqinghasu hemsuccinate FT-0082543 HMS2051I14 HMS2090L16 HSDB 7458 I06-0204 LS-177760 LS-187735 MLS000759445 MLS001424053 MolPort-001-732-325 MolPort-006-392-384 NCI60_039350 NSC712571 Nuartez Plasmotrim Plasmotrin Qinghaozhi Quinghaosu reduced succinate ester S2265_Selleck SAM001246628 SM 804 SMR000466336 STK801911 Succinyl dihydroartemisinin UNII-60W3249T9M WR 256283 WR-256283 artesunato artesunatum artesunic acid butanedioic acid, 1-[(3R,5aS,6R,8aS,9R,10S,12R,12aR)-decahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano[4,3-j]-1,2-benzodioxepin-10-yl] ester dihydroqinghasu hemsuccinate |
|
Interventional clinical trials: (show top 50)
(show all 149)
| id | Name | Status | NCT ID | Phase |
|---|
| 1 | Ketotifen as a Treatment for Vascular Leakage During Dengue Fever | Recruiting | NCT02673840 | Phase 4 | | 2 | Immunity Period After One Dose of Yellow Fever Vaccine in Adults and Children (Paraiba Study) | Recruiting | NCT02555072 | Phase 4 | | 3 | Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS) | Unknown status | NCT00966628 | Phase 3 | | 4 | Clinical Evaluation of Insect Repellent and Insecticide Treated Nets in Lao PDR | Unknown status | NCT00938379 | Phase 3 | | 5 | Study of a Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 11 Years in Malaysia | Completed | NCT01254422 | Phase 3 | | 6 | Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia | Completed | NCT01134263 | Phase 3 | | 7 | Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers | Completed | NCT01411241 | Phase 3 | | 8 | Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers | Completed | NCT01436396 | Phase 3 | | 9 | Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine | Recruiting | NCT02406729 | Phase 3 | | 10 | Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Cervarix® | Recruiting | NCT02979535 | Phase 3 | | 11 | Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children | Recruiting | NCT02747927 | Phase 3 | | 12 | Efficacy and Safety of Ivermectin Against Dengue Infection | Recruiting | NCT02045069 | Phase 2, Phase 3 | | 13 | Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia | Active, not recruiting | NCT01373281 | Phase 3 | | 14 | Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America | Active, not recruiting | NCT01374516 | Phase 3 | | 15 | Study of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Adacel® in Healthy Subjects | Not yet recruiting | NCT02992418 | Phase 3 | | 16 | Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil® | Not yet recruiting | NCT02993757 | Phase 3 | | 17 | The Effect of Chloroquine in the Treatment of Patients With Dengue | Unknown status | NCT00849602 | Phase 1, Phase 2 | | 18 | Chinese and Western Medicine Treatment of Fever Associated With Bleeding Symptoms | Unknown status | NCT01973855 | Phase 2 | | 19 | A Phase I/II Trial of a Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naïve Children | Completed | NCT00384670 | Phase 1, Phase 2 | | 20 | A Phase I/II Trial of Tetravalent Live Attenuated Dengue Vaccine in Flavivirus Antibody Naive Infants | Completed | NCT00322049 | Phase 1, Phase 2 | | 21 | Study of a Tetravalent Dengue Vaccine in Healthy Adult Subjects Aged 18 to 45 Years in India | Completed | NCT01550289 | Phase 2 | | 22 | A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines | Completed | NCT01064141 | Phase 2 | | 23 | Study of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Subjects in Singapore | Completed | NCT00880893 | Phase 2 | | 24 | Study of CYD Dengue Vaccine in Healthy Children and Adolescents in South America | Completed | NCT01187433 | Phase 2 | | 25 | A Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults | Completed | NCT00239577 | Phase 2 | | 26 | A Phase I/II Trial of a Tetravalent Live Attenuated DEN Vaccine in Flavivirus Antibody Naive Children | Completed | NCT01843621 | Phase 1, Phase 2 | | 27 | Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine | Completed | NCT01488890 | Phase 2 | | 28 | Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine | Completed | NCT01943825 | Phase 2 | | 29 | Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Subjects | Completed | NCT00875524 | Phase 2 | | 30 | Immunogenicity and Safety of Three Formulations of Dengue Vaccines in Healthy Adults Aged 18 to 45 Years in the US | Completed | NCT00617344 | Phase 2 | | 31 | Study of ChimeriVax™ Dengue Tetravalent Vaccine in Adult Subjects | Completed | NCT00730288 | Phase 2 | | 32 | Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America | Completed | NCT00993447 | Phase 2 | | 33 | Efficacy and Safety of Dengue Vaccine in Healthy Children | Completed | NCT00842530 | Phase 2 | | 34 | Prospective Surveillance of Febrile Illness for Dengue-Endemic Areas in Asia | Completed | NCT01218906 | Phase 2 | | 35 | Study of Febrile Illness for Dengue-Endemic Areas in Latin America | Completed | NCT01293331 | Phase 1, Phase 2 | | 36 | A Phase II Trial of a WRAIR Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy US Adults | Completed | NCT00350337 | Phase 2 | | 37 | Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years | Completed | NCT00788151 | Phase 2 | | 38 | Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) | Completed | NCT02193087 | Phase 2 | | 39 | Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 Years | Completed | NCT01511250 | Phase 2 | | 40 | Safety and Immunogenicity of Formulations of Dengue Vaccines in Healthy Flavivirus-Naïve Adults | Completed | NCT00740155 | Phase 2 | | 41 | A Phase II Trial of a Walter Reed Army Institute of Research (WRAIR) Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand | Completed | NCT00370682 | Phase 2 | | 42 | Celgosivir as a Treatment Against Dengue | Completed | NCT01619969 | Phase 1, Phase 2 | | 43 | A Study of Two Doses of WRAIR Dengue Vaccine Administered Six Months Apart to Healthy Adults and Children | Completed | NCT00468858 | Phase 2 | | 44 | Activated Recombinant Human Factor VII in Patients With Dengue Haemorrhagic Fever | Completed | NCT01601613 | Phase 2 | | 45 | The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans | Completed | NCT01943305 | Phase 2 | | 46 | Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule | Recruiting | NCT02824198 | Phase 2 | | 47 | Safety and Immunogenicity of the Dengue Virus Vaccine TV005 (TetraVax-DV TV005) in Healthy Adults, Adolescents, and Children in Dhaka, Bangladesh | Recruiting | NCT02678455 | Phase 2 | | 48 | Evaluating the Safety of and Immune Response to a Dengue Vaccine (TV003) in Healthy Adults, Adolescents, and Children in Thailand | Recruiting | NCT02332733 | Phase 2 | | 49 | Study of Varying Injection Schedules of TDENV-PIV Vaccine With AS03B Adjuvant and Placebo in Healthy US Adults | Recruiting | NCT02421367 | Phase 1, Phase 2 | | 50 | Study of a Booster Dose of a Tetravalent Dengue Vaccine in Subjects Who Previously Completed the 3-dose Schedule | Active, not recruiting | NCT02623725 | Phase 2 |
Cochrane evidence based reviews: dengue
|
